J&J to Lead in Atopic Dermatitis Treatment with Recent Acquisition
Johnson & Johnson has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated…
Johnson & Johnson has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated…